David Sinnott is a seasoned quality management professional with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as Associate Director of Quality Management at Eli Lilly and Company since October 2025, David previously held similar roles at Verve Therapeutics and Solid Biosciences, where responsibilities included quality assurance auditing and management of quality systems and supplier quality. David's background also includes significant positions at Alnylam Pharmaceuticals and Shire, with expertise in providing quality oversight for manufacturing and quality control processes. David holds a Master of Science in Drug Regulatory Affairs from Northeastern University and a Bachelor of Science in Chemistry from Bridgewater State University, complemented by minors in Physics and Mathematics.
This person is not in any teams
This person is not in any offices